Nu Skin Enterprises Inc. (NYSE:NUS) Director Andrew D. Lipman sold 30,000 shares of the company’s stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $64.13, for a total value of $1,923,900.00. Following the completion of the transaction, the director now directly owns 36,090 shares in the company, valued at $2,314,451.70. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Nu Skin Enterprises Inc. (NYSE:NUS) opened at 63.12 on Friday. Nu Skin Enterprises Inc. has a 52 week low of $23.51 and a 52 week high of $64.48. The company’s 50-day moving average price is $59.04 and its 200-day moving average price is $46.28. The company has a market capitalization of $3.53 billion, a P/E ratio of 36.21 and a beta of 1.75.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.01. The business had revenue of $600.05 million for the quarter, compared to analyst estimates of $578.87 million. Nu Skin Enterprises had a return on equity of 18.46% and a net margin of 4.52%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.75 EPS. On average, equities analysts forecast that Nu Skin Enterprises Inc. will post $2.88 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 14th. Shareholders of record on Friday, August 26th were issued a $0.355 dividend. This represents a $1.42 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 81.14%.
A number of equities analysts have issued reports on the company. Jefferies Group upped their target price on Nu Skin Enterprises from $53.00 to $61.00 and gave the company a “hold” rating in a research report on Thursday. Citigroup Inc. upped their target price on Nu Skin Enterprises from $66.00 to $69.00 and gave the company a “buy” rating in a research report on Wednesday. TheStreet raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Thursday, August 4th. Deutsche Bank AG upped their target price on Nu Skin Enterprises from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Friday, August 5th. Finally, Stifel Nicolaus upped their target price on Nu Skin Enterprises from $34.00 to $45.00 and gave the company a “sell” rating in a research report on Friday, August 5th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $50.72.
A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Fund Advisors raised its stake in Nu Skin Enterprises by 589.5% in the first quarter. BlackRock Fund Advisors now owns 3,824,996 shares of the company’s stock worth $146,306,000 after buying an additional 3,270,255 shares during the period. AJO LP raised its stake in Nu Skin Enterprises by 47.7% in the second quarter. AJO LP now owns 1,953,104 shares of the company’s stock worth $90,214,000 after buying an additional 631,121 shares during the period. Waddell & Reed Financial Inc. acquired a new stake in Nu Skin Enterprises during the second quarter worth about $18,291,000. SkyBridge Capital II LLC acquired a new stake in Nu Skin Enterprises during the second quarter worth about $15,216,000. Finally, JPMorgan Chase & Co. raised its stake in Nu Skin Enterprises by 72.2% in the first quarter. JPMorgan Chase & Co. now owns 671,872 shares of the company’s stock worth $25,699,000 after buying an additional 281,592 shares during the period. 77.08% of the stock is currently owned by hedge funds and other institutional investors.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.